Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    POMDOCTOR Ltd (POM)

    Price:

    0.42 USD

    ( + 0.04 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    POM
    Name
    POMDOCTOR Ltd
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    Price
    0.420
    Market Cap
    44.915M
    Enterprise value
    3.917B
    Currency
    USD
    Ceo
    Zhenyang Shi
    Full Time Employees
    156
    Website
    Ipo Date
    2025-10-08
    City
    Guangzhou
    Address
    Yongxu Industrial Park

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Bio Green Med Solution, Inc.

    VALUE SCORE:

    7

    Symbol
    BGMSP
    Market Cap
    6.557M
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    2nd position

    Insmed Incorporated

    VALUE SCORE:

    8

    Symbol
    INSM
    Market Cap
    42.019B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    The best

    BeOne Medicines Ltd.

    VALUE SCORE:

    9

    Symbol
    ONC
    Market Cap
    34.088B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -2.448
    P/S
    0.925
    P/B
    -0.155
    Debt/Equity
    -0.195
    EV/FCF
    -46.405
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    2.190
    Earnings yield
    -0.409
    Debt/assets
    9.542
    FUNDAMENTALS
    Net debt/ebidta
    -17.862
    Interest coverage
    -1.989
    Research And Developement To Revenue
    0.009
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.002
    Capex to revenue
    0.000
    Capex to depreciation
    0.281
    Return on tangible assets
    -3.101
    Debt to market cap
    1.392
    Piotroski Score
    FUNDAMENTALS
    PEG
    -0.003
    P/CF
    -21.756
    P/FCF
    -19.597
    RoA %
    -310.120
    RoIC %
    44.030
    Gross Profit Margin %
    13.923
    Quick Ratio
    0.158
    Current Ratio
    0.209
    Net Profit Margin %
    -41.850
    Net-Net
    -17.878
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.137
    Revenue per share
    2.892
    Net income per share
    -1.210
    Operating cash flow per share
    -0.136
    Free cash flow per share
    -0.137
    Cash per share
    0.065
    Book value per share
    -17.685
    Tangible book value per share
    -17.685
    Shareholders equity per share
    -19.110
    Interest debt per share
    3.834
    TECHNICAL
    52 weeks high
    6.430
    52 weeks low
    0.260
    Current trading session High
    0.520
    Current trading session Low
    0.367
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    -1.3233986%
    P/E
    -8.687
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -9.476
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -7.125
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    24.705
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -7.974
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -19.408
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -42.243
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.171
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.266
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -33.454
    DESCRIPTION

    Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

    NEWS
    https://images.financialmodelingprep.com/news/pomdoctor-limited-announces-first-half-of-fiscal-2025-unaudited-20251203.jpg
    POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results

    prnewswire.com

    2025-12-03 16:15:00

    GUANGZHOU, China , Dec. 3, 2025 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced its unaudited financial results for the six months ended June 30, 2025. Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented: "The first half of fiscal year 2025 reflected our deliberate and disciplined efforts to balance business expansion with operational rigor.

    https://images.financialmodelingprep.com/news/citi-appointed-as-depositary-bank-for-pomdoctor-limiteds-adr-20251017.jpg
    Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program

    businesswire.com

    2025-10-17 13:47:00

    NEW YORK--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank, N.A., has been appointed by POMDOCTOR LIMITED (POM), a Chinese online medical services platform, as Depositary Bank for its American Depositary Receipt (ADR) program. The American Depositary Shares (ADS) of POM trade on the Nasdaq Stock Exchange under the ticker “POM”. Every six (6) ADSs represent one (1) Class A ordinary share of POM. The initial public offering price is US$4.00 per ADS in connection with a total offerin.

    https://images.financialmodelingprep.com/news/us-ipo-weekly-recap-6-ipos-debut-pipeline-grows-despite-20251011.jpg
    U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown

    seekingalpha.com

    2025-10-11 01:10:00

    Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and five SPACs also submitted initial filings. No traditional IPOs are currently scheduled for the week ahead as the government shutdown continues to mostly pause new issuance.

    https://images.financialmodelingprep.com/news/pomdoctor-limited-announces-full-exercise-and-closing-of-underwriters-overallotment-20251010.jpg
    POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option

    prnewswire.com

    2025-10-10 17:15:00

    GUANGZHOU, China , Oct. 10, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the underwriter of its initial public offering (the "Offering") has exercised in full its option to purchase an additional 750,000 American Depositary Shares ("ADSs") at a public offering price of $4.00 per ADS to cover over-allotments. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company.

    https://images.financialmodelingprep.com/news/pomdoctor-debuts-on-nasdaq-ahead-of-new-listing-rules-20251010.png
    PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules

    benzinga.com

    2025-10-10 05:57:25

    The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 million

    https://images.financialmodelingprep.com/news/pomdoctor-limited-announces-closing-of-initial-public-offering-20251009.jpg
    POMDOCTOR LIMITED Announces Closing of Initial Public Offering

    prnewswire.com

    2025-10-09 16:05:00

    GUANGZHOU, China , Oct. 9, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the closing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at a public offering price of US$4.00 per ADS. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company.

    https://images.financialmodelingprep.com/news/pomdoctor-limited-announces-pricing-of-initial-public-offering-20251008.jpg
    POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

    prnewswire.com

    2025-10-08 08:00:00

    GUANGZHOU, China , Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the pricing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at a public offering price of US$4.00 per ADS. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company.

    https://images.financialmodelingprep.com/news/china-strikes-back-at-bidens-tariffs-with-new-investigation-20240520.jpeg
    China Strikes Back At Biden's Tariffs With New Investigation Into Plastics Imports: 6 Stocks Caught In Crossfire

    http://feeds.benzinga.com

    2024-05-20 17:22:01

    China has taken a new step in the ongoing economic battle with the west, launching a new anti-dumping probe of plastics made in the U.S. and the European Union. The move can be read as a possible retaliation against recent protectionist measures by Western countries, including a recent increase of tariffs on Chinese imports led by President Joe Biden. The Chinese probe was announced on Sunday by the country's commerce ministry, looking into imports of polyoxymethylene copolymer, a type of plastic widely used in consumer electronics, household items, car parts as well as in industrial applications. Public companies manufacturing this material include Celanese Corporation CE, BASF SE BASFY, DuPont de Nemours, Inc. DD, Mitsubishi Chemical Holdings Corporation MTLHY, Asahi Kasei Corporation AHKSY and SABIC (Saudi Basic Industries Corporation) SABRY. Over the next year, China will look into imports of the chemical, also known acetal or POM, coming from the U.S., Japan, Taiwan and the EU, in efforts to find out if imports are being priced at equal levels to their domestic markets. In an anti-dumping probe, a country will try to assess whether companies from a different country are pricing items at lower prices in order to gain market share and take out the local competition. The probe could be extended for a period of six months after the one-year period is completed. Also read: Chinese EV Maker Li Auto Misses Q1 Revenue Expectations Despite Surging Vehicle Sales, Stock Tanks Is China Striking Back? Biden's measures from last week struck a nerve in China as the U.S. government pushed forward a plan to further protect U.S. manufacturing jobs by imposing higher tariffs on Chinese goods. The heavy taxes include a 25% tariff on Chinese steel and aluminum, a new 100% tariff on Chinese electric vehicles, a 25% tariff on EV batteries and critical minerals, upsized tariffs on Chinese solar panels, raised from 25% to 50%, and a new 50% tariff on semiconductors made in China. The move is said to directly benefit U.S. carmakers Ford Motor Co F and General Motors Co GM. Biden's recent measures are part of an all-out campaign to attract undecided voters by pushing protectionist measures aimed at safeguarding U.S. jobs and industrial capabilities. His GOP opponent Donald Trump, who has boasted the more protectionist, anti-China discourse in recent years, maintains a one-point lead, according to the most recent polls. EU Eyes Chinese EVs, Steel, More: Biden's new tariffs build on previous ones imposed by Trump during the previous White House administration. The new tariff announcement synced with another blow to Chinese international commerce coming from across the Atlantic. The European Commission, which is the executive arm of the European Union, is halfway through a probe looking at whether the bloc should impose tariffs on Chinese electric vehicles, following the example of the U.S. Last week, the EU announced several new probes aimed at finding out whether Chinese companies are benefiting from state subsidies that could allow them to market cheaper products in Europe, therefore displacing European companies. The investigations, being carried out by the European Commission, are centered on iron or steel products coming from China, as well as wood flooring and medical devices. Several Chinese products associated with the production of clean energy, including wind turbines, solar panels, are also being researched by the bloc, according to Reuters. Now read: ‘Oh My Word:’ Tesla FSD Wows Boris Johnson As It Drives His Family Around ‘Hair-Raising’ LA Roads; Ex-UK Leader Reveals New Feature In Works Shutterstock illustration. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    https://images.financialmodelingprep.com/news/pepco-holdings-schedules-conference-call-firstquarter-2014-earnings-review-20140421.jpg
    Pepco Holdings Schedules Conference Call; First-Quarter 2014 Earnings Review

    businesswire.com

    2014-04-21 11:49:00

    WASHINGTON--(BUSINESS WIRE)--Pepco Holdings, Inc. (NYSE: POM) has scheduled an earnings conference call at 10 a.m. ET, Wednesday, May 7. First-quarter 2014 earnings will be released before the market opens on Wednesday, May 7. Investors, members of the media and other interested persons may access the conference call on the Internet at http://www.pepcoholdings.com/investors or by calling 1-800-638-4817 before 9:55 a.m. The pass code for the call is 42691241. International callers may access the call by dialing 1-617-614-3943, using the same pass code 42691241. An on-demand replay will be available for seven days following the call. To hear the replay, dial 1-888-286-8010 and enter pass code 21609069. International callers may access the replay by dialing 1-617-801-6888 and entering the same pass code 21609069. An audio archive will be available at PHI's website, http://www.pepcoholdings.com/investors. Note: If any non-GAAP financial information (as defined by the Securities and Exchange Commission in Regulation G and excluding information furnished in a Form 8-K) is used during the quarterly earnings conference call, a presentation of the most directly comparable GAAP measure and a reconciliation of the differences will be available at http://www.pepcoholdings.com/investors promptly after the conclusion of the conference call. Pepco Holdings, Inc. (NYSE: POM) is one of the largest energy delivery companies in the Mid-Atlantic region, serving about 2 million customers in Delaware, the District of Columbia, Maryland and New Jersey. PHI subsidiaries Pepco, Delmarva Power and Atlantic City Electric provide regulated electricity service; Delmarva Power also provides natural gas service. PHI also provides energy efficiency and renewable energy services through Pepco Energy Services.

    https://images.financialmodelingprep.com/news/pepco-holdings-schedules-conference-call-fourthquarter-2013-earnings-review-20140211.jpg
    Pepco Holdings Schedules Conference Call; Fourth-Quarter 2013 Earnings Review

    businesswire.com

    2014-02-11 12:20:00

    WASHINGTON--(BUSINESS WIRE)--Pepco Holdings, Inc. (NYSE: POM) has scheduled an earnings conference call at 10 a.m. ET, Friday, Feb. 28. Fourth-quarter 2013 earnings will be released before the market opens on Friday, Feb. 28. Investors, members of the media and other interested persons may access the conference call on the Internet at http://www.pepcoholdings.com/investors or by calling 1-877-474-9502 before 9:55 a.m. The pass code for the call is 76221242. International callers may access the call by dialing 1-857-244-7555, using the same pass code 76221242. An on-demand replay will be available for seven days following the call. To hear the replay, dial 1-888-286-8010 and enter pass code 59090463. International callers may access the replay by dialing 1-617-801-6888 and entering the same pass code 59090463. An audio archive will be available at PHI's website, http://www.pepcoholdings.com/investors. Note: If any non-GAAP financial information (as defined by the Securities and Exchange Commission in Regulation G and excluding information furnished in a Form 8-K) is used during the quarterly earnings conference call, a presentation of the most directly comparable GAAP measure and a reconciliation of the differences will be available at http://www.pepcoholdings.com/investors promptly after the conclusion of the conference call. Pepco Holdings, Inc. (NYSE: POM) is one of the largest energy delivery companies in the Mid-Atlantic region, serving about 2 million customers in Delaware, the District of Columbia, Maryland and New Jersey. PHI subsidiaries Pepco, Delmarva Power and Atlantic City Electric provide regulated electricity service; Delmarva Power also provides natural gas service. PHI also provides energy efficiency and renewable energy services through Pepco Energy Services.